Rodent studies utilizing drugs similar to ibudilast show axonal regeneration after SCI.17 Human studies in multiple sclerosis demonstrate reduced lesion sizes and increased tissue sparing.59 Investigators hypothesize that ibudilast mediates neuroprotection via phosphodiesterase 4 (PDE4) inhibition and reduced inflammation. Here, PDE4A is linked to multiple sclerosis.